Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05705804
NA
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
Sponsor: Yonsei University
View on ClinicalTrials.gov
Summary
The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2023-06-13
Completion Date
2027-06-01
Last Updated
2026-07-07
Healthy Volunteers
No
Interventions
DRUG
Pitavastatin
Pitavastatin 4 mg will be given.
DRUG
Pitavastatin plus Ezetemibe
Pitvastatin 4 mg plus ezetemibe 10 mg will be given.
DRUG
Atorvastatin
Atorvastatin 40 mg will be given.
Locations (1)
Yonsei University Health System, Severance Hospital
Seoul, South Korea